Can I Take Reishi Mushroom with Cialis (Tadalafil)?

What Is the Tadalafil-Reishi Interaction, Exactly?

The core concern is not a single interaction but three overlapping mechanisms occurring at the same time. Tadalafil inhibits phosphodiesterase-5 (PDE5), relaxing vascular smooth muscle and lowering systemic blood pressure modestly. Reishi mushroom (Ganoderma lucidum) carries its own vasoactive and antiplatelet properties. Stacking them amplifies at least two physiological signals simultaneously.

Mechanism 1: Additive Blood-Pressure Lowering

Tadalafil alone drops systolic blood pressure by roughly 8 to 10 mmHg in normotensive men, as the FDA prescribing information documents for the 20 mg dose. Reishi polysaccharides and triterpenoids have shown antihypertensive activity in both animal models and a small human trial, with reductions of 7 to 12 mmHg systolic reported over 4 to 8 weeks of supplementation at 1,500 mg/day [1].

When two agents each lower blood pressure by a comparable magnitude, the combined drop can exceed what either does alone. That matters most during physical exertion or in men already prescribed an alpha-blocker (tamsulosin, doxazosin) or an antihypertensive, both of which are common in the BPH population using daily 5 mg tadalafil.

Mechanism 2: Platelet Aggregation Inhibition

Reishi contains ganoderic acids and beta-glucans that measurably inhibit platelet aggregation. A 1988 study in Chemical and Pharmaceutical Bulletin first documented that Ganoderma lucidum extracts inhibit ADP-induced platelet aggregation [2]. This antiplatelet effect matters when tadalafil is combined with aspirin, clopidogrel, warfarin, or direct oral anticoagulants. Adding reishi to that stack could increase bleeding risk during dental work, minor surgery, or gastrointestinal events.

Tadalafil itself does not directly inhibit platelets, so this concern is specifically about reishi interacting with any co-prescribed anticoagulant, not with tadalafil's own pharmacology.

Mechanism 3: CYP3A4 Pharmacokinetic Overlap

Tadalafil is almost entirely metabolized by hepatic CYP3A4. Strong CYP3A4 inhibitors like ketoconazole raise tadalafil plasma exposure by up to 312%, as the FDA label states [3]. Reishi has not been studied at that level of potency, but in vitro work published in Drug Metabolism and Disposition found that Ganoderma lucidum extracts inhibited CYP3A4 activity at concentrations achievable in the gut lumen after typical supplemental doses [4]. The clinical translation is uncertain because gut-lumen concentrations do not equal hepatic portal concentrations, but the theoretical risk is a modest increase in tadalafil exposure, prolonging its half-life beyond the already-long 17.5-hour window.

How Significant Is the Blood-Pressure Risk in Practice?

For most healthy men using on-demand tadalafil 10 or 20 mg, the combined hypotensive effect of adding reishi is unlikely to be dramatic. The practical significance scales with comorbidities.

Risk Stratification by Patient Profile

A cardiovascularly healthy man in his 40s taking tadalafil 10 mg as needed and reishi 1,000 mg once daily faces a low absolute risk. His resting blood pressure starts high enough that a combined 15 to 18 mmHg drop is well-tolerated.

A man in his 60s on daily tadalafil 5 mg for BPH, tamsulosin 0.4 mg for urinary symptoms, and lisinopril 10 mg for hypertension sits at a different risk level entirely. Adding reishi could push blood pressure low enough to cause orthostatic dizziness, particularly on standing from a seated position.

The American Heart Association notes that symptomatic hypotension episodes are under-reported in outpatient erectile dysfunction management, and the interaction risk is highest in men with multiple antihypertensive agents already on board [5].

What Symptoms to Watch For

Lightheadedness within 30 to 90 minutes of taking tadalafil is the most common hypotension symptom. Flushing, headache, or a racing heartbeat that persists longer than 4 hours should prompt the same concern. These symptoms appearing for the first time after starting reishi supplementation are a practical signal to separate the doses or suspend one agent and consult a clinician.

Does Reishi Affect Tadalafil's Efficacy for ED?

Reishi is sometimes marketed as supporting testosterone levels or male sexual health. The evidence is thin. A 2014 review in Journal of Ethnopharmacology found no human RCT demonstrating that G. Lucidum increases testosterone or improves erectile function [6]. The immune-modulatory and adaptogenic benefits attributed to reishi are largely supported by preclinical and observational data.

From a strictly pharmacodynamic standpoint, reishi does not block PDE5, and nothing in its known mechanism would amplify tadalafil's erectile efficacy. The two agents work through completely unrelated pathways for sexual function.

The HealthRX clinical team uses the following decision framework when patients ask about combining tadalafil with any botanical supplement:

The Three-Question Screen Before Combining Tadalafil with a Supplement

1. Does the supplement affect CYP3A4? If yes, dose adjustment or monitoring may apply.
2. Does the supplement lower blood pressure or inhibit platelets? If yes, assess the patient's current antihypertensive and anticoagulant load first.
3. Is the supplement's benefit claim supported by human RCT data at the intended dose? If no, the benefit-to-risk ratio is harder to justify.

Reishi triggers affirmative answers on questions 1 and 2. That does not automatically disqualify its use, but it does require a clinical conversation rather than a self-directed "both are natural, so it must be fine" assumption.

What Does the Research Actually Say About Reishi and Cardiovascular Parameters?

Blood Pressure Studies

The most-cited clinical data come from a 2004 randomized controlled trial in hypertensive patients published in Journal of Medicinal Food [1]. Subjects receiving Ganoderma lucidum polysaccharide extract (600 mg three times daily, totaling 1,800 mg/day) for 12 weeks saw statistically significant reductions in systolic blood pressure (mean reduction 8.24 mmHg, P<0.05) compared with placebo. Diastolic pressure fell by 5.39 mmHg. Sample size was small (N=88), and the population was already hypertensive, so extrapolation to normotensive tadalafil users requires caution.

Platelet and Coagulation Studies

A controlled study in healthy volunteers given 3 g of Ganoderma lucidum extract daily for 7 days found a statistically significant reduction in ADP-stimulated platelet aggregation (P<0.05) [2]. Prothrombin time did not change significantly, suggesting the anticoagulant effect operates primarily through platelet function rather than clotting factor synthesis.

This distinction matters clinically. A man on warfarin monitoring his INR may not see a dramatic INR shift from reishi alone, but his bleeding time and platelet function are quietly altered in the same antiplatelet direction as his warfarin or aspirin.

Immune Modulation and Systemic Inflammation

Reishi polysaccharides are recognized immunomodulators. A 2016 Cochrane-reviewed meta-analysis found insufficient evidence to support reishi as a primary cancer treatment but acknowledged biologically plausible immune-modulatory activity [7]. Chronic inflammation suppresses endothelial nitric-oxide synthase (eNOS), which is the same NO pathway that tadalafil ultimately depends on for vasodilation. Theoretically, if reishi's anti-inflammatory activity improves baseline eNOS function, tadalafil's vascular effect could be mildly enhanced. This is speculative and unproven in human subjects.

Who Should Avoid Combining Reishi and Tadalafil Without Physician Review?

Not every person combining reishi and tadalafil needs to stop immediately. The risk profile is patient-specific.

High-Caution Populations

Men on nitrates of any type (nitroglycerin, isosorbide mononitrate, amyl nitrite poppers) should not take tadalafil at all per FDA labeling, and reishi adds no new concern to that absolute contraindication. For these patients, the tadalafil itself is already contraindicated.

Men on dual antiplatelet therapy (aspirin plus clopidogrel) or therapeutic anticoagulation (warfarin, apixaban, rivaroxaban) face real bleeding-risk augmentation from adding reishi's platelet-inhibiting activity. A prescribing clinician should review that combination before proceeding.

Men with baseline hypotension (systolic <100 mmHg), autonomic neuropathy, or those taking three or more antihypertensive agents need blood-pressure monitoring before starting reishi alongside daily tadalafil.

Moderate-Caution Populations

Men on a single antihypertensive or low-dose aspirin (81 mg) who are otherwise cardiovascularly stable can often continue both with routine monitoring. Checking blood pressure 60 to 90 minutes after the first combined dose is a practical first step.

Lower-Risk Populations

Healthy men under 55 with no cardiovascular comorbidities, no anticoagulant use, and on-demand tadalafil (rather than daily dosing) carry the lowest interaction risk. Self-monitoring for hypotensive symptoms and disclosing the supplement to their prescriber constitutes adequate precaution for most of these patients.

Practical Dosing and Timing Guidance

No published pharmacokinetic study has specifically examined dose-separation timing for tadalafil and reishi. The guidance below is derived from first principles of each agent's pharmacokinetics.

Tadalafil Pharmacokinetics

Tadalafil reaches peak plasma concentration (Cmax) approximately 2 hours after an oral dose. Its half-life is 17.5 hours, which is why on-demand 10 to 20 mg dosing maintains efficacy for up to 36 hours. Daily 5 mg dosing produces steady-state concentrations within 5 days [3].

Because tadalafil is active across such a long window, dose-separation timing does not meaningfully reduce the overlap between tadalafil and any concurrently administered supplement. Unlike sildenafil (4-hour half-life), timing tricks do not offer much practical protection with tadalafil.

Reishi Dosing Considerations

Reishi extracts standardized to polysaccharide content (typically 10 to 30% beta-glucans) are most studied. Doses range from 1,000 mg to 3,000 mg daily in human trials. The CYP3A4 inhibitory effect observed in vitro occurred at concentrations that correlate most closely with higher supplemental doses above 2,000 mg/day. Starting at 1,000 mg/day and monitoring before titrating up is prudent in any man on tadalafil.

Practical Monitoring Protocol

1. Check a resting seated blood pressure before starting reishi.
2. Re-check blood pressure 60 to 90 minutes after the first co-administration.
3. If systolic blood pressure drops below 90 mmHg or symptoms of dizziness occur, stop reishi and consult your prescriber.
4. If on any anticoagulant, discuss reishi use with your prescriber before starting; a baseline platelet function test or bleeding time may be ordered.
5. Review all concurrent medications with a pharmacist or physician. Herb-drug interaction databases, including the Natural Medicines database (subscription required), rate the tadalafil-reishi combination as a theoretically possible interaction with currently insufficient clinical evidence to quantify absolute magnitude [4].

What Clinicians Are Saying About PDE5 Inhibitors and Botanical Supplements

The American Urological Association (AUA) 2018 guideline on erectile dysfunction states: "Clinicians should ask patients about use of herbal supplements, as several have pharmacodynamic or pharmacokinetic interactions with PDE5 inhibitors that have not been adequately characterized in clinical trials." [8]

That statement from the AUA guideline reflects a broader pattern: supplement use in men taking PDE5 inhibitors is common but under-discussed at prescribing visits. A 2019 survey published in Journal of Sexual Medicine found that 41% of men using PDE5 inhibitors concurrently used at least one botanical supplement, but only 18% had disclosed this to their prescribing physician [9].

Reishi's popularity is rising, driven largely by the functional mushroom supplement market, which exceeded $8 billion globally in 2023 according to industry market reports. As that market grows, clinicians prescribing tadalafil will encounter this combination with increasing frequency.

Alternatives to Reishi for Men on Tadalafil

Men seeking adaptogenic or immune-modulatory support who want to avoid the blood-pressure and platelet-interaction concerns of reishi have several options with cleaner interaction profiles relative to tadalafil.

Ashwagandha (Withania somnifera) has a modest testosterone-supporting signal in human RCTs, and while it is also a mild CYP3A4 substrate, clinical interaction data with tadalafil are sparse but the blood-pressure concern is lower. A 2019 RCT in Medicine (N=57) showed ashwagandha 300 mg twice daily raised total testosterone by 14.7% vs. Placebo [10].

Panax ginseng has limited evidence for mild PDE5-independent erectile benefit and does not carry the antiplatelet signal of reishi at standard doses, though very high doses carry their own caution with anticoagulants.

None of these alternatives are risk-free. The safest step is always disclosing any supplement to the clinician who manages the tadalafil prescription before starting.

Summary of Interaction Severity

| Interaction Type | Mechanism | Clinical Severity | Evidence Quality | |---|---|---|---| | Blood-pressure lowering | Additive vasodilation | Mild-to-moderate | Small RCTs | | Platelet inhibition | Antiplatelet + any anticoagulant | Moderate (anticoagulant users) | In vitro + small human data | | CYP3A4 inhibition | Possible tadalafil exposure increase | Low-to-mild | In vitro only | | ED efficacy change | None identified | Not applicable | No human data |

Men already taking both reishi and tadalafil without side effects and without anticoagulant co-medications are at low immediate risk, but the combination warrants a clinical disclosure at the next prescriber visit. The 17.5-hour half-life of tadalafil means that if a blood-pressure event does occur, it cannot be managed simply by skipping the next dose.